The trial evidence is worth reporting plainly, because it is not what the marketing suggests
Most GLP-1 agonists (semaglutide, liraglutide, dulaglutide, tirzepatide) do not require dose adjustment for mild-to-moderate renal impairment, though caution is warranted in severe renal impairment
Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites
Here, we observed that serum creatinine was positively associated with TMAO AUC difference between placebo and pomegranate interventions ( = 26.0, 95% CI: 11.4, 40.6
Athletes, Fitness enthusiasts, Bodybuilders or those leading a physically active lifestyle